nodes	percent_of_prediction	percent_of_DWPC	metapath
Menadione—NQO1—Carboplatin—ovarian cancer	0.273	0.418	CbGbCtD
Menadione—NQO1—Doxorubicin—ovarian cancer	0.156	0.239	CbGbCtD
Menadione—XDH—Carboplatin—ovarian cancer	0.143	0.218	CbGbCtD
Menadione—XDH—Doxorubicin—ovarian cancer	0.0818	0.125	CbGbCtD
Menadione—F2—vein—ovarian cancer	0.00938	0.0523	CbGeAlD
Menadione—PROZ—testis—ovarian cancer	0.00423	0.0236	CbGeAlD
Menadione—F9—epithelium—ovarian cancer	0.00381	0.0213	CbGeAlD
Menadione—PROS1—Vinblastine—Vinorelbine—ovarian cancer	0.00368	0.583	CbGdCrCtD
Menadione—VKORC1L1—decidua—ovarian cancer	0.00355	0.0198	CbGeAlD
Menadione—PROC—bone marrow—ovarian cancer	0.00319	0.0178	CbGeAlD
Menadione—F9—gonad—ovarian cancer	0.00317	0.0177	CbGeAlD
Menadione—F7—female reproductive system—ovarian cancer	0.00297	0.0165	CbGeAlD
Menadione—GGCX—myometrium—ovarian cancer	0.0029	0.0162	CbGeAlD
Menadione—BGLAP—embryo—ovarian cancer	0.00286	0.0159	CbGeAlD
Menadione—F9—female reproductive system—ovarian cancer	0.00283	0.0158	CbGeAlD
Menadione—VKORC1L1—female reproductive system—ovarian cancer	0.00279	0.0156	CbGeAlD
Menadione—PROS1—myometrium—ovarian cancer	0.00275	0.0154	CbGeAlD
Menadione—F7—female gonad—ovarian cancer	0.0027	0.015	CbGeAlD
Menadione—NQO1—Vincristine—Vinorelbine—ovarian cancer	0.00263	0.417	CbGdCrCtD
Menadione—F9—female gonad—ovarian cancer	0.00258	0.0144	CbGeAlD
Menadione—F9—vagina—ovarian cancer	0.00256	0.0143	CbGeAlD
Menadione—VKORC1L1—female gonad—ovarian cancer	0.00254	0.0142	CbGeAlD
Menadione—VKORC1L1—vagina—ovarian cancer	0.00253	0.0141	CbGeAlD
Menadione—F7—testis—ovarian cancer	0.00239	0.0133	CbGeAlD
Menadione—F9—testis—ovarian cancer	0.00229	0.0128	CbGeAlD
Menadione—GGCX—uterine cervix—ovarian cancer	0.00225	0.0126	CbGeAlD
Menadione—VKORC1L1—testis—ovarian cancer	0.00225	0.0126	CbGeAlD
Menadione—GGCX—decidua—ovarian cancer	0.00215	0.012	CbGeAlD
Menadione—PROS1—uterine cervix—ovarian cancer	0.00214	0.0119	CbGeAlD
Menadione—PROS1—decidua—ovarian cancer	0.00204	0.0114	CbGeAlD
Menadione—GGCX—endometrium—ovarian cancer	0.00204	0.0114	CbGeAlD
Menadione—F10—uterine cervix—ovarian cancer	0.00202	0.0112	CbGeAlD
Menadione—PROS1—endometrium—ovarian cancer	0.00194	0.0108	CbGeAlD
Menadione—F10—decidua—ovarian cancer	0.00192	0.0107	CbGeAlD
Menadione—GGCX—uterus—ovarian cancer	0.00188	0.0105	CbGeAlD
Menadione—NQO2—myometrium—ovarian cancer	0.00184	0.0103	CbGeAlD
Menadione—F10—endometrium—ovarian cancer	0.00182	0.0102	CbGeAlD
Menadione—PROS1—uterus—ovarian cancer	0.00179	0.00996	CbGeAlD
Menadione—BGLAP—female reproductive system—ovarian cancer	0.00173	0.00965	CbGeAlD
Menadione—XDH—uterine cervix—ovarian cancer	0.00173	0.00965	CbGeAlD
Menadione—GGCX—female reproductive system—ovarian cancer	0.00169	0.00942	CbGeAlD
Menadione—VKORC1L1—lymph node—ovarian cancer	0.00163	0.00912	CbGeAlD
Menadione—BGLAP—bone marrow—ovarian cancer	0.00163	0.00911	CbGeAlD
Menadione—VKORC1—gonad—ovarian cancer	0.00162	0.00904	CbGeAlD
Menadione—PROS1—female reproductive system—ovarian cancer	0.0016	0.00895	CbGeAlD
Menadione—XDH—endometrium—ovarian cancer	0.00156	0.00872	CbGeAlD
Menadione—NQO1—myometrium—ovarian cancer	0.00154	0.00858	CbGeAlD
Menadione—GGCX—female gonad—ovarian cancer	0.00154	0.00857	CbGeAlD
Menadione—GGCX—vagina—ovarian cancer	0.00153	0.00852	CbGeAlD
Menadione—PROS1—bone marrow—ovarian cancer	0.00152	0.00845	CbGeAlD
Menadione—F10—female reproductive system—ovarian cancer	0.00151	0.00842	CbGeAlD
Menadione—PROS1—female gonad—ovarian cancer	0.00146	0.00814	CbGeAlD
Menadione—PROS1—vagina—ovarian cancer	0.00145	0.00809	CbGeAlD
Menadione—F2—epithelium—ovarian cancer	0.00145	0.00808	CbGeAlD
Menadione—VKORC1—female reproductive system—ovarian cancer	0.00145	0.00808	CbGeAlD
Menadione—NQO2—uterine cervix—ovarian cancer	0.00143	0.00798	CbGeAlD
Menadione—AOX1—myometrium—ovarian cancer	0.00141	0.00788	CbGeAlD
Menadione—F10—female gonad—ovarian cancer	0.00137	0.00766	CbGeAlD
Menadione—F10—vagina—ovarian cancer	0.00137	0.00762	CbGeAlD
Menadione—GGCX—testis—ovarian cancer	0.00136	0.0076	CbGeAlD
Menadione—NQO2—decidua—ovarian cancer	0.00136	0.0076	CbGeAlD
Menadione—VKORC1—female gonad—ovarian cancer	0.00132	0.00735	CbGeAlD
Menadione—XDH—female reproductive system—ovarian cancer	0.0013	0.00723	CbGeAlD
Menadione—PROS1—testis—ovarian cancer	0.0013	0.00722	CbGeAlD
Menadione—NQO2—endometrium—ovarian cancer	0.00129	0.00722	CbGeAlD
Menadione—F10—testis—ovarian cancer	0.00122	0.0068	CbGeAlD
Menadione—NQO1—epithelium—ovarian cancer	0.00121	0.00674	CbGeAlD
Menadione—NQO1—uterine cervix—ovarian cancer	0.0012	0.00668	CbGeAlD
Menadione—NQO2—uterus—ovarian cancer	0.00119	0.00665	CbGeAlD
Menadione—XDH—vagina—ovarian cancer	0.00117	0.00654	CbGeAlD
Menadione—VKORC1—testis—ovarian cancer	0.00117	0.00652	CbGeAlD
Menadione—NQO1—decidua—ovarian cancer	0.00114	0.00636	CbGeAlD
Menadione—AOX1—uterine cervix—ovarian cancer	0.0011	0.00613	CbGeAlD
Menadione—MAOB—myometrium—ovarian cancer	0.00109	0.00607	CbGeAlD
Menadione—NQO1—endometrium—ovarian cancer	0.00108	0.00604	CbGeAlD
Menadione—F2—female reproductive system—ovarian cancer	0.00108	0.006	CbGeAlD
Menadione—MTHFR—female reproductive system—ovarian cancer	0.00108	0.006	CbGeAlD
Menadione—NQO2—female reproductive system—ovarian cancer	0.00107	0.00598	CbGeAlD
Menadione—AOX1—decidua—ovarian cancer	0.00105	0.00584	CbGeAlD
Menadione—MAOB—embryo—ovarian cancer	0.00105	0.00584	CbGeAlD
Menadione—F2—bone marrow—ovarian cancer	0.00102	0.00567	CbGeAlD
Menadione—NQO2—bone marrow—ovarian cancer	0.00101	0.00564	CbGeAlD
Menadione—NQO1—uterus—ovarian cancer	0.000998	0.00557	CbGeAlD
Menadione—AOX1—endometrium—ovarian cancer	0.000994	0.00554	CbGeAlD
Menadione—GGCX—lymph node—ovarian cancer	0.000988	0.00551	CbGeAlD
Menadione—MTHFR—female gonad—ovarian cancer	0.000979	0.00546	CbGeAlD
Menadione—F2—female gonad—ovarian cancer	0.000979	0.00546	CbGeAlD
Menadione—NQO2—female gonad—ovarian cancer	0.000976	0.00544	CbGeAlD
Menadione—NQO2—vagina—ovarian cancer	0.00097	0.00541	CbGeAlD
Menadione—PROS1—lymph node—ovarian cancer	0.000939	0.00524	CbGeAlD
Menadione—AOX1—gonad—ovarian cancer	0.000922	0.00514	CbGeAlD
Menadione—AOX1—uterus—ovarian cancer	0.000916	0.00511	CbGeAlD
Menadione—NQO1—female reproductive system—ovarian cancer	0.000897	0.00501	CbGeAlD
Menadione—F10—lymph node—ovarian cancer	0.000884	0.00493	CbGeAlD
Menadione—MTHFR—testis—ovarian cancer	0.000869	0.00484	CbGeAlD
Menadione—NQO2—testis—ovarian cancer	0.000865	0.00483	CbGeAlD
Menadione—VKORC1—lymph node—ovarian cancer	0.000847	0.00472	CbGeAlD
Menadione—MAOB—uterine cervix—ovarian cancer	0.000847	0.00472	CbGeAlD
Menadione—AOX1—female reproductive system—ovarian cancer	0.000823	0.00459	CbGeAlD
Menadione—NQO1—female gonad—ovarian cancer	0.000817	0.00455	CbGeAlD
Menadione—NQO1—vagina—ovarian cancer	0.000812	0.00453	CbGeAlD
Menadione—MAOB—decidua—ovarian cancer	0.000807	0.0045	CbGeAlD
Menadione—CYP2A6—vagina—ovarian cancer	0.000778	0.00434	CbGeAlD
Menadione—MAOB—endometrium—ovarian cancer	0.000766	0.00427	CbGeAlD
Menadione—AOX1—female gonad—ovarian cancer	0.000749	0.00418	CbGeAlD
Menadione—AOX1—vagina—ovarian cancer	0.000745	0.00415	CbGeAlD
Menadione—NQO1—testis—ovarian cancer	0.000724	0.00404	CbGeAlD
Menadione—MAOB—uterus—ovarian cancer	0.000706	0.00394	CbGeAlD
Menadione—AOX1—testis—ovarian cancer	0.000665	0.00371	CbGeAlD
Menadione—MAOB—female reproductive system—ovarian cancer	0.000635	0.00354	CbGeAlD
Menadione—MTHFR—lymph node—ovarian cancer	0.00063	0.00351	CbGeAlD
Menadione—NQO2—lymph node—ovarian cancer	0.000627	0.0035	CbGeAlD
Menadione—CYP1A1—epithelium—ovarian cancer	0.0006	0.00335	CbGeAlD
Menadione—CYP1A1—uterine cervix—ovarian cancer	0.000595	0.00332	CbGeAlD
Menadione—MAOB—female gonad—ovarian cancer	0.000577	0.00322	CbGeAlD
Menadione—MAOB—vagina—ovarian cancer	0.000574	0.0032	CbGeAlD
Menadione—NQO1—lymph node—ovarian cancer	0.000525	0.00293	CbGeAlD
Menadione—MAOB—testis—ovarian cancer	0.000512	0.00286	CbGeAlD
Menadione—CYP1A1—uterus—ovarian cancer	0.000496	0.00276	CbGeAlD
Menadione—AOX1—lymph node—ovarian cancer	0.000482	0.00269	CbGeAlD
Menadione—CYP1A1—female reproductive system—ovarian cancer	0.000446	0.00248	CbGeAlD
Menadione—CYP2E1—female reproductive system—ovarian cancer	0.000406	0.00227	CbGeAlD
Menadione—CYP1A1—female gonad—ovarian cancer	0.000405	0.00226	CbGeAlD
Menadione—CYP1A1—vagina—ovarian cancer	0.000403	0.00225	CbGeAlD
Menadione—MAOB—lymph node—ovarian cancer	0.000371	0.00207	CbGeAlD
Menadione—CYP2E1—testis—ovarian cancer	0.000328	0.00183	CbGeAlD
Menadione—CYP1A1—lymph node—ovarian cancer	0.000261	0.00145	CbGeAlD
Menadione—F10—Hemostasis—TP53—ovarian cancer	3.03e-05	0.000189	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.03e-05	0.000189	CbGpPWpGaD
Menadione—PROS1—Innate Immune System—AKT1—ovarian cancer	3.03e-05	0.000189	CbGpPWpGaD
Menadione—MTHFR—Disease—IL6ST—ovarian cancer	3.03e-05	0.000189	CbGpPWpGaD
Menadione—XDH—Metabolism—TYMS—ovarian cancer	3.01e-05	0.000188	CbGpPWpGaD
Menadione—MAOB—Metabolism—PPP2R1A—ovarian cancer	3e-05	0.000188	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYTB—ovarian cancer	3e-05	0.000187	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EREG—ovarian cancer	2.96e-05	0.000185	CbGpPWpGaD
Menadione—AOX1—Disease—IL6ST—ovarian cancer	2.96e-05	0.000185	CbGpPWpGaD
Menadione—F2—Hemostasis—IL2—ovarian cancer	2.91e-05	0.000182	CbGpPWpGaD
Menadione—MTHFR—Disease—APC—ovarian cancer	2.91e-05	0.000182	CbGpPWpGaD
Menadione—F10—Hemostasis—HRAS—ovarian cancer	2.9e-05	0.000181	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—MMP2—ovarian cancer	2.88e-05	0.00018	CbGpPWpGaD
Menadione—AOX1—Disease—APC—ovarian cancer	2.84e-05	0.000177	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYTB—ovarian cancer	2.82e-05	0.000176	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—NME2—ovarian cancer	2.79e-05	0.000175	CbGpPWpGaD
Menadione—MAOB—Metabolism—ABCB1—ovarian cancer	2.79e-05	0.000174	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PGR—ovarian cancer	2.78e-05	0.000173	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.76e-05	0.000172	CbGpPWpGaD
Menadione—MAOB—Metabolism—TYMS—ovarian cancer	2.74e-05	0.000171	CbGpPWpGaD
Menadione—PROS1—Immune System—STAT3—ovarian cancer	2.74e-05	0.000171	CbGpPWpGaD
Menadione—PROS1—Immune System—NRAS—ovarian cancer	2.73e-05	0.00017	CbGpPWpGaD
Menadione—NQO1—Metabolism—CAV1—ovarian cancer	2.71e-05	0.000169	CbGpPWpGaD
Menadione—MTHFR—Metabolism—CAV1—ovarian cancer	2.67e-05	0.000167	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PPP1CC—ovarian cancer	2.62e-05	0.000164	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—BRIP1—ovarian cancer	2.62e-05	0.000164	CbGpPWpGaD
Menadione—PROS1—Immune System—MAPK3—ovarian cancer	2.61e-05	0.000163	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PIK3CG—ovarian cancer	2.61e-05	0.000163	CbGpPWpGaD
Menadione—AOX1—Metabolism—CAV1—ovarian cancer	2.61e-05	0.000163	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PARP1—ovarian cancer	2.58e-05	0.000161	CbGpPWpGaD
Menadione—F10—Hemostasis—AKT1—ovarian cancer	2.56e-05	0.00016	CbGpPWpGaD
Menadione—MTHFR—Disease—PIK3CD—ovarian cancer	2.56e-05	0.00016	CbGpPWpGaD
Menadione—AOX1—Disease—PIK3CD—ovarian cancer	2.5e-05	0.000156	CbGpPWpGaD
Menadione—PROS1—Immune System—MAPK1—ovarian cancer	2.49e-05	0.000155	CbGpPWpGaD
Menadione—PROS1—Immune System—EGFR—ovarian cancer	2.49e-05	0.000155	CbGpPWpGaD
Menadione—F2—Hemostasis—VEGFA—ovarian cancer	2.47e-05	0.000154	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL6ST—ovarian cancer	2.47e-05	0.000154	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—BRIP1—ovarian cancer	2.47e-05	0.000154	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PPP1CC—ovarian cancer	2.47e-05	0.000154	CbGpPWpGaD
Menadione—NQO1—Metabolism—PIK3CG—ovarian cancer	2.47e-05	0.000154	CbGpPWpGaD
Menadione—F2—Hemostasis—NRAS—ovarian cancer	2.44e-05	0.000153	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PIK3CG—ovarian cancer	2.44e-05	0.000152	CbGpPWpGaD
Menadione—XDH—Metabolism—CAV1—ovarian cancer	2.43e-05	0.000152	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CXCL8—ovarian cancer	2.4e-05	0.00015	CbGpPWpGaD
Menadione—AOX1—Metabolism—PIK3CG—ovarian cancer	2.38e-05	0.000149	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PIK3CG—ovarian cancer	2.37e-05	0.000148	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.37e-05	0.000148	CbGpPWpGaD
Menadione—PROS1—Immune System—KRAS—ovarian cancer	2.35e-05	0.000147	CbGpPWpGaD
Menadione—F2—Hemostasis—MAPK3—ovarian cancer	2.34e-05	0.000146	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PIK3CD—ovarian cancer	2.3e-05	0.000143	CbGpPWpGaD
Menadione—MTHFR—Disease—ERBB2—ovarian cancer	2.26e-05	0.000141	CbGpPWpGaD
Menadione—MTHFR—Disease—MTOR—ovarian cancer	2.23e-05	0.000139	CbGpPWpGaD
Menadione—MTHFR—Disease—PIK3CB—ovarian cancer	2.23e-05	0.000139	CbGpPWpGaD
Menadione—F2—Hemostasis—MAPK1—ovarian cancer	2.23e-05	0.000139	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—YAP1—ovarian cancer	2.22e-05	0.000139	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CG—ovarian cancer	2.21e-05	0.000138	CbGpPWpGaD
Menadione—F2—Metabolism of proteins—CTNNB1—ovarian cancer	2.21e-05	0.000138	CbGpPWpGaD
Menadione—MAOB—Metabolism—CAV1—ovarian cancer	2.21e-05	0.000138	CbGpPWpGaD
Menadione—AOX1—Disease—ERBB2—ovarian cancer	2.21e-05	0.000138	CbGpPWpGaD
Menadione—AOX1—Disease—MTOR—ovarian cancer	2.18e-05	0.000136	CbGpPWpGaD
Menadione—AOX1—Disease—PIK3CB—ovarian cancer	2.18e-05	0.000136	CbGpPWpGaD
Menadione—NQO1—Metabolism—PIK3CD—ovarian cancer	2.17e-05	0.000135	CbGpPWpGaD
Menadione—PROS1—Immune System—PIK3CA—ovarian cancer	2.16e-05	0.000135	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PIK3CD—ovarian cancer	2.14e-05	0.000134	CbGpPWpGaD
Menadione—F2—Hemostasis—KRAS—ovarian cancer	2.1e-05	0.000131	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PPP2R1A—ovarian cancer	2.09e-05	0.000131	CbGpPWpGaD
Menadione—AOX1—Metabolism—PIK3CD—ovarian cancer	2.09e-05	0.000131	CbGpPWpGaD
Menadione—MTHFR—Disease—CDKN1B—ovarian cancer	2.09e-05	0.000131	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PIK3CD—ovarian cancer	2.09e-05	0.00013	CbGpPWpGaD
Menadione—AOX1—Disease—CDKN1B—ovarian cancer	2.04e-05	0.000128	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CG—ovarian cancer	2.01e-05	0.000126	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PIK3CB—ovarian cancer	2e-05	0.000125	CbGpPWpGaD
Menadione—PROS1—Immune System—HRAS—ovarian cancer	2e-05	0.000125	CbGpPWpGaD
Menadione—MTHFR—Disease—CTNNB1—ovarian cancer	1.98e-05	0.000123	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CD—ovarian cancer	1.94e-05	0.000121	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.93e-05	0.000121	CbGpPWpGaD
Menadione—F2—Hemostasis—PIK3CA—ovarian cancer	1.93e-05	0.000121	CbGpPWpGaD
Menadione—AOX1—Disease—CTNNB1—ovarian cancer	1.93e-05	0.000121	CbGpPWpGaD
Menadione—MTHFR—Disease—PTEN—ovarian cancer	1.93e-05	0.00012	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—CXCL8—ovarian cancer	1.92e-05	0.00012	CbGpPWpGaD
Menadione—PROS1—Immune System—IL6—ovarian cancer	1.91e-05	0.000119	CbGpPWpGaD
Menadione—NQO1—Metabolism—PIK3CB—ovarian cancer	1.89e-05	0.000118	CbGpPWpGaD
Menadione—AOX1—Disease—PTEN—ovarian cancer	1.88e-05	0.000117	CbGpPWpGaD
Menadione—F2—Hemostasis—TP53—ovarian cancer	1.87e-05	0.000117	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PIK3CB—ovarian cancer	1.87e-05	0.000117	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—IL2—ovarian cancer	1.84e-05	0.000115	CbGpPWpGaD
Menadione—AOX1—Metabolism—PIK3CB—ovarian cancer	1.82e-05	0.000114	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PIK3CB—ovarian cancer	1.82e-05	0.000114	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—FASN—ovarian cancer	1.81e-05	0.000113	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYTB—ovarian cancer	1.8e-05	0.000112	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.8e-05	0.000112	CbGpPWpGaD
Menadione—F2—Hemostasis—HRAS—ovarian cancer	1.79e-05	0.000112	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—SLC5A5—ovarian cancer	1.78e-05	0.000111	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CD—ovarian cancer	1.77e-05	0.00011	CbGpPWpGaD
Menadione—PROS1—Immune System—AKT1—ovarian cancer	1.76e-05	0.00011	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.76e-05	0.00011	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—YAP1—ovarian cancer	1.76e-05	0.00011	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—CXCL8—ovarian cancer	1.75e-05	0.000109	CbGpPWpGaD
Menadione—MTHFR—Disease—STAT3—ovarian cancer	1.72e-05	0.000108	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—SLC2A1—ovarian cancer	1.72e-05	0.000107	CbGpPWpGaD
Menadione—MTHFR—Disease—NRAS—ovarian cancer	1.72e-05	0.000107	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CB—ovarian cancer	1.7e-05	0.000106	CbGpPWpGaD
Menadione—AOX1—Disease—STAT3—ovarian cancer	1.68e-05	0.000105	CbGpPWpGaD
Menadione—AOX1—Disease—NRAS—ovarian cancer	1.68e-05	0.000105	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL2—ovarian cancer	1.67e-05	0.000104	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TERT—ovarian cancer	1.66e-05	0.000104	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—YAP1—ovarian cancer	1.66e-05	0.000103	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.65e-05	0.000103	CbGpPWpGaD
Menadione—MTHFR—Disease—MAPK3—ovarian cancer	1.65e-05	0.000103	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.64e-05	0.000102	CbGpPWpGaD
Menadione—NQO1—Metabolism—PTEN—ovarian cancer	1.63e-05	0.000102	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PTEN—ovarian cancer	1.61e-05	0.000101	CbGpPWpGaD
Menadione—AOX1—Disease—MAPK3—ovarian cancer	1.61e-05	0.0001	CbGpPWpGaD
Menadione—MTHFR—Disease—MYC—ovarian cancer	1.6e-05	0.0001	CbGpPWpGaD
Menadione—F2—Hemostasis—AKT1—ovarian cancer	1.58e-05	9.85e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—PTEN—ovarian cancer	1.58e-05	9.84e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.57e-05	9.83e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.57e-05	9.83e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—MAPK1—ovarian cancer	1.57e-05	9.78e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—EGFR—ovarian cancer	1.57e-05	9.78e-05	CbGpPWpGaD
Menadione—AOX1—Disease—MYC—ovarian cancer	1.56e-05	9.76e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CB—ovarian cancer	1.54e-05	9.62e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CAV1—ovarian cancer	1.54e-05	9.61e-05	CbGpPWpGaD
Menadione—AOX1—Disease—MAPK1—ovarian cancer	1.53e-05	9.55e-05	CbGpPWpGaD
Menadione—AOX1—Disease—EGFR—ovarian cancer	1.53e-05	9.55e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ESR1—ovarian cancer	1.48e-05	9.26e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—KRAS—ovarian cancer	1.48e-05	9.24e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PTEN—ovarian cancer	1.46e-05	9.15e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.46e-05	9.14e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6ST—ovarian cancer	1.46e-05	9.11e-05	CbGpPWpGaD
Menadione—AOX1—Disease—KRAS—ovarian cancer	1.44e-05	9.02e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.44e-05	9e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—FASN—ovarian cancer	1.43e-05	8.94e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—SLC5A5—ovarian cancer	1.41e-05	8.79e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—APC—ovarian cancer	1.4e-05	8.76e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CG—ovarian cancer	1.4e-05	8.76e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—NRAS—ovarian cancer	1.4e-05	8.76e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—SLC2A1—ovarian cancer	1.36e-05	8.49e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—PIK3CA—ovarian cancer	1.36e-05	8.49e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.36e-05	8.49e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—FASN—ovarian cancer	1.35e-05	8.43e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—MAPK3—ovarian cancer	1.34e-05	8.38e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—TYMS—ovarian cancer	1.33e-05	8.33e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PTEN—ovarian cancer	1.33e-05	8.31e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—SLC5A5—ovarian cancer	1.33e-05	8.29e-05	CbGpPWpGaD
Menadione—AOX1—Disease—PIK3CA—ovarian cancer	1.33e-05	8.29e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CYP1B1—ovarian cancer	1.3e-05	8.14e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—SLC2A1—ovarian cancer	1.28e-05	8.01e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—MAPK1—ovarian cancer	1.28e-05	7.98e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—EGFR—ovarian cancer	1.28e-05	7.98e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—HRAS—ovarian cancer	1.26e-05	7.85e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.26e-05	7.84e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CD—ovarian cancer	1.23e-05	7.7e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CYP1B1—ovarian cancer	1.23e-05	7.68e-05	CbGpPWpGaD
Menadione—AOX1—Disease—HRAS—ovarian cancer	1.23e-05	7.67e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—PIK3CA—ovarian cancer	1.22e-05	7.62e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—KRAS—ovarian cancer	1.21e-05	7.54e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—IL6—ovarian cancer	1.2e-05	7.51e-05	CbGpPWpGaD
Menadione—AOX1—Disease—IL6—ovarian cancer	1.18e-05	7.34e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PPP2R1A—ovarian cancer	1.16e-05	7.22e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—PIK3CA—ovarian cancer	1.15e-05	7.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.15e-05	7.16e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—PIK3CA—ovarian cancer	1.14e-05	7.11e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—PIK3CA—ovarian cancer	1.11e-05	6.94e-05	CbGpPWpGaD
Menadione—MTHFR—Disease—AKT1—ovarian cancer	1.11e-05	6.93e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—PIK3CA—ovarian cancer	1.11e-05	6.92e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	1.09e-05	6.81e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—ERBB2—ovarian cancer	1.09e-05	6.8e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.08e-05	6.78e-05	CbGpPWpGaD
Menadione—AOX1—Disease—AKT1—ovarian cancer	1.08e-05	6.77e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—CAV1—ovarian cancer	1.08e-05	6.72e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MTOR—ovarian cancer	1.07e-05	6.71e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CB—ovarian cancer	1.07e-05	6.71e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—ABCB1—ovarian cancer	1.07e-05	6.71e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—YAP1—ovarian cancer	1.06e-05	6.59e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—TYMS—ovarian cancer	1.05e-05	6.59e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.04e-05	6.53e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—PIK3CA—ovarian cancer	1.03e-05	6.45e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CXCL8—ovarian cancer	1.03e-05	6.45e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—HRAS—ovarian cancer	1.03e-05	6.41e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—ABCB1—ovarian cancer	1.01e-05	6.32e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CDKN1B—ovarian cancer	1.01e-05	6.3e-05	CbGpPWpGaD
Menadione—F2—GPCR downstream signaling—AKT1—ovarian cancer	9.97e-06	6.23e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—TYMS—ovarian cancer	9.94e-06	6.21e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CASP3—ovarian cancer	9.88e-06	6.17e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL2—ovarian cancer	9.86e-06	6.16e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—IL6—ovarian cancer	9.82e-06	6.13e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CG—ovarian cancer	9.79e-06	6.12e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CCND1—ovarian cancer	9.62e-06	6.01e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—CTNNB1—ovarian cancer	9.52e-06	5.95e-05	CbGpPWpGaD
Menadione—NQO1—Metabolism—AKT1—ovarian cancer	9.41e-06	5.88e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—PIK3CA—ovarian cancer	9.39e-06	5.87e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MMP9—ovarian cancer	9.34e-06	5.83e-05	CbGpPWpGaD
Menadione—MTHFR—Metabolism—AKT1—ovarian cancer	9.3e-06	5.81e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PTEN—ovarian cancer	9.28e-06	5.8e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.18e-06	5.74e-05	CbGpPWpGaD
Menadione—AOX1—Metabolism—AKT1—ovarian cancer	9.08e-06	5.67e-05	CbGpPWpGaD
Menadione—F2—Signaling by GPCR—AKT1—ovarian cancer	9.06e-06	5.66e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CD—ovarian cancer	8.61e-06	5.38e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—FASN—ovarian cancer	8.61e-06	5.37e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—CAV1—ovarian cancer	8.5e-06	5.31e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.47e-06	5.29e-05	CbGpPWpGaD
Menadione—XDH—Metabolism—AKT1—ovarian cancer	8.44e-06	5.27e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—VEGFA—ovarian cancer	8.38e-06	5.24e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—STAT3—ovarian cancer	8.3e-06	5.18e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—NRAS—ovarian cancer	8.28e-06	5.17e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—SLC2A1—ovarian cancer	8.18e-06	5.11e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—CAV1—ovarian cancer	8.01e-06	5e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	8.01e-06	5e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MAPK3—ovarian cancer	7.93e-06	4.95e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.84e-06	4.9e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CG—ovarian cancer	7.74e-06	4.83e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MYC—ovarian cancer	7.71e-06	4.82e-05	CbGpPWpGaD
Menadione—MAOB—Metabolism—AKT1—ovarian cancer	7.67e-06	4.79e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.65e-06	4.78e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—MAPK1—ovarian cancer	7.55e-06	4.71e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—EGFR—ovarian cancer	7.54e-06	4.71e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CB—ovarian cancer	7.5e-06	4.69e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CG—ovarian cancer	7.3e-06	4.56e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—KRAS—ovarian cancer	7.13e-06	4.45e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	6.95e-06	4.34e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.92e-06	4.32e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CD—ovarian cancer	6.8e-06	4.25e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—PIK3CA—ovarian cancer	6.55e-06	4.09e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PTEN—ovarian cancer	6.48e-06	4.05e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.45e-06	4.03e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CD—ovarian cancer	6.42e-06	4.01e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—TYMS—ovarian cancer	6.34e-06	3.96e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—TP53—ovarian cancer	6.33e-06	3.96e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—HRAS—ovarian cancer	6.06e-06	3.78e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CB—ovarian cancer	5.93e-06	3.7e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—IL6—ovarian cancer	5.8e-06	3.62e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CB—ovarian cancer	5.59e-06	3.49e-05	CbGpPWpGaD
Menadione—F2—Signaling Pathways—AKT1—ovarian cancer	5.35e-06	3.34e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PTEN—ovarian cancer	5.12e-06	3.2e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—CAV1—ovarian cancer	5.11e-06	3.19e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.88e-06	3.05e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PTEN—ovarian cancer	4.83e-06	3.02e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.65e-06	2.91e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—PIK3CA—ovarian cancer	4.57e-06	2.86e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CD—ovarian cancer	4.09e-06	2.55e-05	CbGpPWpGaD
Menadione—CYP2A6—Metabolism—AKT1—ovarian cancer	3.74e-06	2.33e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—PIK3CA—ovarian cancer	3.62e-06	2.26e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.57e-06	2.23e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—PIK3CA—ovarian cancer	3.41e-06	2.13e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PTEN—ovarian cancer	3.08e-06	1.92e-05	CbGpPWpGaD
Menadione—CYP2E1—Metabolism—AKT1—ovarian cancer	2.95e-06	1.84e-05	CbGpPWpGaD
Menadione—CYP1A1—Metabolism—AKT1—ovarian cancer	2.78e-06	1.74e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.17e-06	1.36e-05	CbGpPWpGaD
Menadione—CYP1A2—Metabolism—AKT1—ovarian cancer	1.78e-06	1.11e-05	CbGpPWpGaD
